Furthermore, we identify a novel molecular mechanism involving the EGFR-ProT-NF-κB-HOTAIR signaling axis in bladder cancer cachexia induced by cisplatin chemotherapy. The gene discussed is NFKB1; the disease is urinary bladder carcinoma.